Osaic Holdings
BBIO icon

Osaic Holdings’s BridgeBio Pharma BBIO Stock Holding History

Osaic Holdings’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
217,577
+493
+0.2% +$34.5K 0.02% 757
2026
Q1 		$16.1M Sell
217,084
-35,061
-14% -$2.54M 0.02% 661
2025
Q4 		$19.3M Sell
252,145
-7,913
-3% -$519K 0.03% 596
2025
Q3 		$13.5M Buy
260,058
+255,891
+6,141% +$12.5M 0.02% 830
2025
Q2 		$179K Buy
4,167
+2,858
+218% +$104K ﹤0.01% 4037
2025
Q1 		$45.3K Sell
1,309
-1,921
-59% -$64.8K ﹤0.01% 4792
2024
Q4 		$86.4K Sell
3,230
-15,514
-83% -$401K ﹤0.01% 4295
2024
Q3 		$477K Sell
18,744
-1,044
-5% -$27.4K ﹤0.01% 2909
2024
Q2 		$501K Buy
19,788
+1,918
+11% +$52.4K ﹤0.01% 2767
2024
Q1 		$552K Buy
17,870
+2,024
+13% +$68.8K ﹤0.01% 2852
2023
Q4 		$639K Buy
15,846
+13,489
+572% +$405K ﹤0.01% 2946
2023
Q3 		$62.1K Buy
2,357
+134
+6% +$3.8K ﹤0.01% 4834
2023
Q2 		$38.2K Buy
2,223
+178
+9% +$2.68K ﹤0.01% 5113
2023
Q1 		$33.9K Buy
2,045
+235
+13% +$2.74K ﹤0.01% 5223
2022
Q4 		$13K Sell
1,810
-45
-2% -$431 ﹤0.01% 5795
2022
Q3 		$18K Sell
1,855
-86
-4% -$894 ﹤0.01% 5641
2022
Q2 		$18K Buy
1,941
+132
+7% +$1.1K ﹤0.01% 5669
2022
Q1 		$18K Buy
1,809
+83
+5% +$852 ﹤0.01% 5750
2021
Q4 		$28K Sell
1,726
-281
-14% -$11.9K ﹤0.01% 5549
2021
Q3 		$94K Hold
2,007
– – ﹤0.01% 4580
2021
Q2 		$122K Buy
2,007
+341
+20% +$19.5K ﹤0.01% 4307
2021
Q1 		$102K Sell
1,666
-122
-7% -$7.98K ﹤0.01% 4318
2020
Q4 		$127K Buy
1,788
+483
+37% +$23.3K ﹤0.01% 3871
2020
Q3 		$49K Hold
1,305
– – ﹤0.01% 4314
2020
Q2 		$43K Buy
1,305
+475
+57% +$14.5K ﹤0.01% 4281
2020
Q1 		$24K Buy
+830
New +$25.7K ﹤0.01% 4493

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Osaic Holdings's BBIO Position: Q2 2026 in Review

Osaic Holdings increased its BridgeBio Pharma (BBIO) stake by 0.23% in Q2 2026, buying an estimated $34.5K and bringing the position to 217,577 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #757.

Osaic Holdings first reported a position in BBIO in Q1 2020 and has held it in 26 quarters since. The position peaked at $19.3M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Osaic Holdings held 217,577 shares of BridgeBio Pharma worth $16.2M as of Q2 2026.
  • Osaic Holdings bought 493 BridgeBio Pharma shares in Q2 2026, an estimated $34.5K.
  • BridgeBio Pharma made up 0.02% of Osaic Holdings's portfolio in Q2 2026, its #757 holding.
  • Osaic Holdings first reported a position in BridgeBio Pharma in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's BridgeBio Pharma position peaked at $19.3M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.